HIV molecular immunology database

 

Patient Detail

Patient Code CAP045 (CAP45)
Patient Sex Female
Risk Factor
Infection Country ZA
Infection City
Infection Year
HLA Type A*23:01, A*29:02, B*15:10, B*45:01, C*16:01, C*16:02
Patient Ethnicity Black
Progression Elite Controller (EC)
Species human
Patient Note Subject CAP045 first positive for vRNA at 45 years with clade-C HIV-1, Fiebig Stage I/II, and virus setpoint 871 copies/ml. At Fiebig Stage I/II, CD4+ count was 306 cells/µl, last sequencing being performed 440 and 636 days after then. Subject CAP45 first positive for vRNA at 41 years with clade-C HIV-1, Fiebig Stage I/II, and virus setpoint <2000 copies/ml. At Fiebig Stage I/II, CD4+ count was >350 cells/µl in the absence of ART. Abrahams2013. CAP45's complete T-cell response was examined using peptides composed of autologous founder sequence and subsequent evolutionary variants [Liu2013a; PMID: 23221345].
CTL CD8+ Records 58948, 58949, 61032, 61037, 61038, 61039, 61040, 61041, 61042, 62312, 62313, 62316
T-Helper CD4+ Records
Antibody Records
Sequence Database Patient ID Record 20442
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health